Ensysce Biosciences Inc (ENSC) — Capital Reinvestment Ratio
Latest as of March 2020:
0.00x
Ensysce Biosciences Inc (ENSC) has a Capital Reinvestment Ratio of 0.00x as of March 2020, meaning it reinvests 0% of its operating cash flow ($136.09 Million) in capital expenditures ($4.00). See free cash flow generation of Ensysce Biosciences Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.00x
Capex / Operating Cash Flow
Operating Cash Flow
$136.09 Million
USD
Capital Expenditures
$4.00
USD
Data as of
Mar 2020
Most recent filing
Ensysce Biosciences Inc Capital Reinvestment Ratio (2019–2019)
This chart tracks Ensysce Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Ensysce Biosciences Inc (2019–2019)
Year-by-year Capital Reinvestment Ratio for Ensysce Biosciences Inc from 2019 to 2019. For live market cap and broader valuation context, see Ensysce Biosciences Inc stock valuation.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.00x | $10.99 Million | $4.00 | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow